EPO PATENT
March has come and gone and with it a significant amount of controversy…. so, are lawyers smarter than software engineers?
who is smarter: lawyers or software engineers?
is this who you want to be doing your legal work?
more patent press release nonsense
An Action... read more
Congratulations to our very own Kati McClatchey on the publication of yet another article entitled THE EUROPEAN PATENT OFFICE AND THE EUROPEAN PATENT: AN OPEN AVENUE FOR BIOTECHNOLOGISTS AND "LIVING INVENTIONS."
Kati discusses "the function and jurisdiction of the European Patent... read more
Congratulations to our very own Kati McClatchey on the publication of her article entitled THE EFFECT OF THE �ONCO-MOUSE� DECISIONS ON THE EXCEPTION TO PATENTABILITY FOR �ANIMAL VARIETIES� UNDER THE EUROPEAN PATENT CONVENTION.
This article gives great a great review of the European patent... read more
IP Law & Business reports an interesting way to quickly stop someone from using your idea.
Since patents generally take years to issue, the idea of a patent "emergency" seems counterintuitive. The referenced article shows that time is often critical for new inventions. One... read more
The European Patent Office
(EPO)
approved a restricted patent on the Harvard OncoMouse.
The EPO on July 6 limited
the patent to mice;
the original European patent, covered all mammalian species with a
transgenic oncogene. That patent had already been restricted in 2001
to only rodents. The EPO's... read more